Impact of the Clinical Pharmacist in Rheumatology Practice: A Systematic Review
Open Access
- 23 July 2024
- journal article
- review article
- Published by MDPI AG in Healthcare
- Vol. 12 (15) , 1463
Abstract
This is a systematic literature review on the impact of pharmacists in rheumatology, conducted using the PubMed®, CINAHL®, Cochrane Library®, and Web of science® databases and using the PRISMA 2020 checklist. This review was conducted from 2000 to June 2024. A quality analysis was performed. The selection of articles, as well as all analyses, including quality analyses, were conducted by a pair of pharmacists with experience in rheumatology, and included 24 articles. This study highlights the growth of clinical pharmacy activities in rheumatology and the positive influence of clinical pharmacists on patient care. The implementation of such initiatives has the potential to improve medication adherence, reduce medication-related risks, and optimize associated healthcare costs. All these pharmaceutical interventions aim to make the patient care journey smoother and safer. Additionally, the diversity of available pharmaceutical services caters to the varied needs of rheumatology. Furthermore, outpatient clinical pharmacy is also explored in this field and garners interest from patients. The vast majority of studies demonstrate significant improvement in patient care with promising performance outcomes when pharmacists are involved. This review highlights the diverse range of interventions by clinical pharmacists in rheumatology, which is very promising. However, to better assess the benefits of clinical pharmacists, this activity needs further development and evaluation through controlled and randomized clinical research programs.Keywords
This publication has 44 references indexed in Scilit:
- European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paperInternational Journal of Clinical Pharmacy, 2022
- Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot studyClinical Rheumatology, 2021
- The impact of an in-department pharmacist on the prevention of drug iatrogenesis in a rheumatology departmentClinical Rheumatology, 2021
- The impact of pharmaceutical care on the efficacy and safety of transdermal glucosamine sulfate and capsaicin for joint painInternational Journal of Clinical Pharmacy, 2020
- Clinical Pharmacy Services in Older Inpatients: An Evidence-Based ReviewDrugs & Aging, 2020
- Pharmacist-managed titration of urate-lowering therapy to streamline gout managementRheumatology International, 2019
- Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized TrialThe American Journal of Medicine, 2019
- Prescribing error at hospital discharge: a retrospective review of medication information in an Irish hospitalIrish Journal of Medical Science (1971 -), 2017
- Patient Satisfaction with Pharmacist‐Led Collaborative Follow‐Up Care in an Ambulatory Rheumatology ClinicMusculoskeletal Care, 2016
- Improving osteoarthritis detection in the community: Pharmacist identification of new, diagnostically confirmed osteoarthritisArthritis Care & Research, 2007